Salud financiera de hoja de balance de J. B. Chemicals & Pharmaceuticals
Salud financiera controles de criterios 5/6
J. B. Chemicals & Pharmaceuticals tiene unos fondos propios totales de ₹27.2B y una deuda total de ₹4.3B, lo que sitúa su ratio deuda/fondos propios en 15.7%. Sus activos y pasivos totales son ₹38.0B y ₹10.8B respectivamente. J. B. Chemicals & Pharmaceuticals El EBIT de la empresa es de ₹7.0B, por lo que su ratio de cobertura de intereses es de 17.1. Su tesorería e inversiones a corto plazo ascienden a ₹3.9B.
Información clave
16.6%
Ratio deuda-patrimonio
₹4.50b
Deuda
| Ratio de cobertura de intereses | 16.5x |
| Efectivo | ₹3.93b |
| Patrimonio | ₹27.17b |
| Total pasivo | ₹10.82b |
| Activos totales | ₹37.99b |
Actualizaciones recientes sobre salud financiera
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Recent updates
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?
Aug 03Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Jun 14How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?
May 04Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Mar 13This Insider Has Just Sold Shares In J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Feb 28Análisis de la situación financiera
Pasivos a corto plazo: JBCHEPHARMLos activos a corto plazo (₹17.6B) de la empresa superan a sus pasivos a corto plazo (₹6.4B).
Pasivo a largo plazo: JBCHEPHARMLos activos a corto plazo (₹17.6B) superan a sus pasivos a largo plazo (₹4.4B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: JBCHEPHARM(2.1%) se considera satisfactoria.
Reducción de la deuda: JBCHEPHARMha pasado de 1.8% a 16.6% en los últimos 5 años.
Cobertura de la deuda: JBCHEPHARMLa deuda de la empresa está bien cubierta por el flujo de caja operativo (170.5%).
Cobertura de intereses: JBCHEPHARMLos pagos de intereses de su deuda están bien cubiertos por el EBIT (16.5x cobertura).